Globeflex Capital’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Globeflex Capital’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-134,160	Closed	-$1.87M	–	510
2023 Q2	$1.87M	Buy	+134,160	New	+$2.29M	0.21%	122
2023 Q1	–	Sell	-42,339	Closed	-$583K	–	519
2022 Q4	$583K	Hold	42,339	–	–	0.07%	234
2022 Q3	$810K	Hold	42,339	–	–	0.14%	195
2022 Q2	$646K	Hold	42,339	–	–	0.16%	184
2022 Q1	$862K	Hold	42,339	–	–	0.17%	164
2021 Q4	$1.24M	Hold	42,339	–	–	0.25%	125
2021 Q3	$913K	Buy	+42,339	New	+$1.02M	0.2%	165
2017 Q1	–	Sell	-187	Closed	–	–	554
2016 Q4	$0	Hold	187	–	–	﹤0.01%	544
2016 Q3	$1K	Hold	187	–	–	﹤0.01%	433
2016 Q2	$0	Hold	187	–	–	﹤0.01%	530
2016 Q1	$1K	Buy	+187	New	+$1K	﹤0.01%	413

Other funds holding CDMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Globeflex Capital's CDMO Position: Q3 2023 in Review

Globeflex Capital sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q3 2023, closing a stake of 134,160 shares — an estimated $1.87M sold.

Globeflex Capital first reported a position in CDMO in Q1 2016 and held it in 11 quarters. The position peaked at $1.87M in Q2 2023. 170 funds tracked by Wall St. Rank hold CDMO as of Q3 2023.

Globeflex Capital reported no remaining Avid Bioservices, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Globeflex Capital sold 134,160 Avid Bioservices, Inc. Common Stock shares in Q3 2023, an estimated $1.87M.
Globeflex Capital first reported a position in Avid Bioservices, Inc. Common Stock in Q1 2016 and held it in 11 quarters.
Globeflex Capital's Avid Bioservices, Inc. Common Stock position peaked at $1.87M in Q2 2023.
170 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q3 2023.

Based on Globeflex Capital's 13F filing for Q3 2023, filed 13 Nov 2023.